Science Explorer Back to mapMap
Discussion

Teva Pharmaceuticals (United States)

In research, Teva Pharmaceuticals (United States) stands highest in Health Sciences (#8,310 of 16,688 worldwide) and Medicine (#7,577 of 14,558 worldwide), over all time.

World rank, 2022-now
#21,380
of 22,385 · #19,844 all time
Rank in United States
#3,157
of 3,332
Research works
463
▼ 56% vs 2018-21
Citations
8.5k
18.3 per fractional work
Top-10% rate
11.2%
all institutions 10.0%
vs its own fields
1.02×
1.00× is exactly expected
Open access
38%
world 40%
International
35%
world 18%

What is Teva Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #8,310 of 16,688 7.4%286
MedicineField #7,577 of 14,558 7.3%274

Each strip is that field's whole ranked pool, with the notch where Teva Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Teva Pharmaceuticals (United States) work in?

In 2022-now, 56% of research at Teva Pharmaceuticals (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (10%), Neuroscience (6%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 39 fractional works · 56.0% of its workMedicine: 37 fractional works · 52.7% of its workPsychiatry and Mental health: 15 fractional works · 21.5% of its workNeurology: 4 fractional works · 5.5% of its workOncology: 2 fractional works · 2.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.7% of its workPhysiology: 2 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.1% of its workPharmacology: 1 fractional works · 2.1% of its workPathology and Forensic Medicine: 1 fractional works · 2.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.7% of its workRheumatology: 1 fractional works · 1.4% of its workEpidemiology: 1 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.2% of its workSurgery: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.3% of its workFamily Practice: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workHealth Professions: 2 fractional works · 3.1% of its workOccupational Therapy: 1 fractional works · 1.2% of its workGeneral Health Professions: 1 fractional works · 0.9% of its workHealth Information Management: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 18 fractional works · 25.0% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 10.4% of its workMolecular Biology: 5 fractional works · 7.2% of its workGenetics: 1 fractional works · 2.0% of its workBiophysics: 0 fractional works · 0.6% of its workCancer Research: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.2% of its workNeuroscience: 4 fractional works · 6.2% of its workCellular and Molecular Neuroscience: 2 fractional works · 2.4% of its workNeurology: 1 fractional works · 1.8% of its workCognitive Neuroscience: 1 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.4% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 4.0% of its workImmunology: 3 fractional works · 4.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 3.8% of its workPharmaceutical Science: 2 fractional works · 2.7% of its workPharmacology: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.6% of its workPhysical Sciences: 7 fractional works · 10.0% of its workComputer Science: 3 fractional works · 3.6% of its workComputational Theory and Mathematics: 1 fractional works · 2.1% of its workArtificial Intelligence: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 2.1% of its workBiomaterials: 1 fractional works · 1.4% of its workPolymers and Plastics: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.5% of its workStatistics and Probability: 1 fractional works · 1.5% of its workEngineering: 1 fractional works · 1.5% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workControl and Systems Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 1 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.5% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workSocial Sciences: 6 fractional works · 9.0% of its workEconomics, Econometrics and Finance: 2 fractional works · 3.5% of its workEconomics and Econometrics: 2 fractional works · 3.5% of its workPsychology: 2 fractional works · 2.8% of its workClinical Psychology: 2 fractional works · 2.4% of its workSocial Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 1 fractional works · 0.9% of its workManagement Information Systems: 0 fractional works · 0.5% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 0.8% of its workGeneral Social Sciences: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.6% of its workPhilosophy: 0 fractional works · 0.6% of its workDecision Sciences: 0 fractional works · 0.5% of its workInformation Systems and Management: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKTevaPharmaceuticals…70fractional works, 2022-now
Life Sciences25%Physical Sciences10%Health Sciences56%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine3752.7%
    2. Health Professions23.1%
    3. Nursing00.1%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology710.4%
    2. Neuroscience46.2%
    3. Immunology and Microbiology34.0%
    4. Pharmacology, Toxicology and Pharmaceutics33.8%
    5. Agricultural and Biological Sciences00.6%
    1. Computer Science33.6%
    2. Materials Science12.1%
    3. Mathematics11.5%
    4. Engineering11.5%
    5. Environmental Science10.8%
    6. Chemistry00.5%
    1. Economics, Econometrics and Finance23.5%
    2. Psychology22.8%
    3. Business, Management and Accounting10.9%
    4. Social Sciences10.8%
    5. Arts and Humanities00.6%
    6. Decision Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.95× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.02× its world share, 3 worksImmunology and Micro…Neuroscience: 3.83× its world share, 4 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.81× its world share, 3 worksPharmacology, Toxico…Chemistry: 0.30× its world share, 0 worksChemistryComputer Science: 0.46× its world share, 2 worksComputer ScienceEngineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.16× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.60× its world share, 2 worksMaterials ScienceMathematics: 1.31× its world share, 1 worksMathematicsHealth Professions: 1.19× its world share, 2 worksHealth ProfessionsMedicine: 2.74× its world share, 37 worksMedicineNursing: 0.21× its world share, 0 worksNursingVeterinary: 0.66× its world share, 0 worksVeterinaryArts and Humanities: 0.20× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.27× its world share, 1 worksBusiness, Management…Decision Sciences: 0.47× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.66× its world share, 2 worksEconomics, Econometr…Psychology: 0.92× its world share, 2 worksPsychologySocial Sciences: 0.06× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.8×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics10.81×3 works
  2. Immunology and Microbiology4.02×3 works
  3. Neuroscience3.83×4 works
  4. Medicine2.74×37 works
  5. Biochemistry, Genetics and Molecular Biology1.95×7 works
  6. Economics, Econometrics and Finance1.66×2 works
  7. Mathematics1.31×1 works
  8. Health Professions1.19×2 works
  9. Psychology0.92×2 works
  10. Veterinary0.66×0 works
  11. Materials Science0.60×2 works
  12. Decision Sciences0.47×0 works
  13. Computer Science0.46×2 works
  14. Chemistry0.30×0 works
  15. Business, Management and Accounting0.27×1 works
  16. Nursing0.21×0 works
  17. Arts and Humanities0.20×0 works
  18. Environmental Science0.16×1 works
  19. Agricultural and Biological Sciences0.12×0 works
  20. Engineering0.10×1 works
  21. Social Sciences0.06×1 works

Who are the top researchers at Teva Pharmaceuticals (United States)?

Ranked on the quality score, Jennifer Stratton, Margaret C. Garin and Richard I. Malamut lead among researchers whose main affiliation is Teva Pharmaceuticals (United States).

  1. 1 Jennifer Stratton United States · #537,864 worldwide 1.7k citations · 49 works
  2. 2 Margaret C. Garin United States · #886,652 worldwide 1.4k citations · 67 works
  3. 3 Richard I. Malamut United States · #909,661 worldwide 2k citations · 43 works
  4. 4 Mark Suett United States · #1,016,117 worldwide 207 citations · 39 works
  5. 5 Kelli R. Franzenburg United States · #1,192,299 worldwide 119 citations · 28 works
  6. 6 Yuju Ma United States · #1,375,543 worldwide 2.4k citations · 35 works
  7. 7 Mark Forrest Gordon United States · #1,437,720 worldwide 7k citations · 152 works
  8. 8 Lindsay Janka United States · #1,693,677 worldwide 1k citations · 18 works
  9. 9 Wenyan David Shen United States · #1,748,501 worldwide 1.6k citations · 28 works
  10. 10 Elizabeth James United States · #1,796,603 worldwide 801 citations · 35 works
All ranked researchers at Teva Pharmaceuticals (United States)

What are the most cited papers from Teva Pharmaceuticals (United States)?

The most cited paper from Teva Pharmaceuticals (United States) is "Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials" (Mario Castro, James Zangrilli, Michael E. Wechsler et al., 2015), with 1,192 citations. Next come "Fremanezumab for the Preventive Treatment of Chronic Migraine" (824) and "Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study" (646).

Most cited papers
#PaperReleasedCitations
1 Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials Mario Castro, James Zangrilli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine 23 Feb 2015 1,192
2 Fremanezumab for the Preventive Treatment of Chronic Migraine Stephen David Silberstein, David W. Dodick, MARCELO EDUARDO BIGAL et al. · New England Journal of Medicine Open access 24 Nov 2017 824
3 Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood Open access 4 Mar 2014 646
4 Animal models of human disease: Challenges in enabling translation Paul McGonigle, Bruce Ruggeri · Biochemical Pharmacology 14 Aug 2013 608
5 Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study David Price, Anna Rigazio, Jonathan D. Campbell et al. · The Lancet Respiratory Medicine Open access 23 Oct 2015 602
All 61 most cited papers, with filters and sorting

Which keywords describe research at Teva Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Neurological Disorders, Calcitonin Gene-Related Peptide, Headache Disorders, Migraine, Monoclonal Antibodies, Immunogenicity, Biopharmaceuticals and Genetics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Neurological Disorders11▲ 27×8 topics
  2. Calcitonin Gene-Related Peptide8▲ 274×2 topics
  3. Headache Disorders8▲ 462×1 topic
  4. Migraine8▲ 269×1 topic
  5. Monoclonal Antibodies5▲ 78×3 topics
  6. Inflammation4▲ 2.6×14 topics
  7. Immunogenicity4▲ 125×3 topics
  8. Machine Learning4▲ 1.61×8 topics
  9. Biopharmaceuticals4▲ 102×3 topics
  10. Genetics4▲ 7.3×9 topics
  11. Quality of Life3▲ 3.3×11 topics
  12. Therapeutic Antibodies3▲ 65×2 topics
  13. Metabolic Syndrome3▲ 5.5×3 topics
  14. Protein Aggregation3▲ 84×2 topics
  15. Antipsychotic Drugs3▲ 108×1 topic
  16. Nanoparticles3▲ 3.4×7 topics
  17. Neurocognitive Deficits3▲ 108×1 topic
  18. Neurobiology3▲ 15×5 topics
  19. Treatment3▲ 3.3×10 topics
  20. Diagnostic Criteria2▲ 16×4 topics
  21. Mitochondrial Dysfunction2▲ 12×4 topics
  22. Parkinson's Disease2▲ 14×6 topics
  23. Drug Delivery2▲ 5.6×4 topics
  24. Neuroimaging2▲ 11×6 topics
  25. Epilepsy2▲ 25×3 topics
  26. Glycosylation2▲ 26×3 topics
  27. Recombinant Proteins2▲ 89×2 topics
  28. Chromatography2▲ 183×1 topic
  29. Stability2▲ 12×1 topic
  30. Pharmacokinetics2▲ 9.6×3 topics
  31. Treatment-Resistant Depression2▲ 38×2 topics
  32. Bioanalytical Methods2▲ 122×1 topic
  33. Biosimilars2▲ 122×1 topic
  34. Cognitive Impairment2▲ 9.8×5 topics
  35. Medicinal Chemistry2▲ 9.1×3 topics
  36. Neurodegeneration2▲ 7.9×3 topics
  37. Central Sensitization2▲ 36×2 topics
  38. Cost-effectiveness Analysis2▲ 29×1 topic
  39. Health Utility Measures2▲ 29×1 topic
  40. Neuropathic Pain2▲ 32×3 topics

Which research topics does Teva Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Migraine and Headache Studies, Schizophrenia research and treatment, Protein purification and stability and Biosimilars and Bioanalytical Methods.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 8 works
  2. 2 Schizophrenia research and treatment Psychiatry and Mental health 3 works
  3. 3 Protein purification and stability Molecular Biology 2 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 2 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  7. 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  8. 8 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  9. 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.0%not open62.0%

World: 40% of research is openly available.

with international co-authors35.3%domestic only64.7%

World: 18% is written across borders.

How has Teva Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 56% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Teva Pharmaceuticals (United States) as a percentage of every work published that year, 0.00031% in 2024.

still counting0.00050%0.0010%0.0015%Teva Pharmaceuticals (United States)0.00016% in 202519801990200020102020

Fractional works of Teva Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%Teva Pharmaceuticals (United States)13.6% in 2022all institutions10.0% in 20222020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 13.6% in 2022.

Other research institutions in North Wales

All research institutions in North Wales

Share Teva Pharmaceuticals (United States)'s ranking

Teva Pharmaceuticals (United States) on Science Explorer

A card with Teva Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Teva Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.